BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Sept. 21, 2020

Sep. 21, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Medical Technology Association, Biocept, Boston Scientific, Dariohealth, Decision Diagnostics, Exagen, Gunze, Hancock Jaffe, Highmark, Hmc Healthworks, Icad, Mimedx, Misonix, Novartis, Ortho Clinical Diagnostics, Polarityte, Radiation Business Solutions, Radmax, Royal Philips, Siemens Healthineers, Startx, Titan Medical.
Read More

Financings for Sept. 21, 2020

Sep. 21, 2020
Med-tech firms raising money in public or private financings, including: American Laboratory Products, Arna Genomics, Cit Group, Protech Home Medical.
Read More

Appointments and advancements for Sept. 21, 2020

Sep. 21, 2020
New hires and promotions in the med-tech industry, including: Kromatid, Silk Road Medical.
Read More

Regulatory actions for Sept. 21, 2020

Sep. 21, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alexion, Ampio, Arca, Astrazeneca, Crinetics, I-Mab, Merck, Otsuka, Harbour and Liminal.
Read More

Other news to note for Sept. 21, 2020

Sep. 21, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alaxia, Astrazeneca, Biocurepharm, Cend, Daré, Dcprime, Elektrofi, Glycotope, Hoth, Impilo, Locate, Macrogenics, Mind, Neurorx, Oncology Venture, Precision, Pharmabcine, Relief, Revive, S&R Biopharm, Samsung, Sojournix, Springworks, Takeda, Xbiotech.
Read More

In the clinic for Sept. 21, 2020

Sep. 21, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 3D, Agios, Alphamab, Aslan, Axsome, Astrazeneca, Beigene, Bridgebio, Incyte, Leap, Macrogenics, Mimedx, Onconova, Retrophin, Seqirus, Tracon, Trevena.
Read More

Financings for Sept. 21, 2020

Sep. 21, 2020
Biopharmas raising money in public or private financings, including: Adicet, Graybug, Kronos, Novellus, Orphazyme, PMV, Prelude, Spruce.
Read More

Appointments and advancements for Sept. 21, 2020

Sep. 21, 2020
New hires and promotions in the biopharma industry, including: Catabasis, Genprex, Legend, Novago, Repertoire, Theolytics, Zogenix.
Read More

Other news to note for Sept. 18, 2020

Sep. 18, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Aeye Health, Bond Digital Health, Cmr Surgical, Foundation Medicine, Fujifilm, HSS, Naval Research Laboratory, National Center for Advancing Translational Sciences, Optomed, Renalytix AI, Siemens Healthineers, Takeda.
Read More

Appointments and advancements for Sept. 18, 2020

Sep. 18, 2020
New hires and promotions in the med-tech industry, including: Nemaura Medical, Real Time Medical.
Read More
Previous 1 2 … 1466 1467 1468 1469 1470 1471 1472 1473 1474 … 1738 1739 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing